Feedback / Questions
clazakizumab IV (ALD518 IV) - CSL Behring, NYU Langone Health
http://clinicaltrials.gov/ct2/show/NCT04381052
Apr 8, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next